Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T Candidate from Ongoing Multi-target Strategic Collaboration
Bristol Myers Squibb exercised its first option and entered into a global license agreement with Immatics for the most a…
Bristol Myers Squibb exercised its first option and entered into a global license agreement with Immatics for the most a…